炎症
Online ISSN : 1884-4006
Print ISSN : 0389-4290
ISSN-L : 0389-4290
新抗炎症薬CS-600のプロスタグランジン生合成阻害を中心とする薬効作用機序
松田 啓一大西 清方謝 智恵山崎 光郎田中 頼久田中 喜一郎
著者情報
ジャーナル フリー

1982 年 2 巻 3 号 p. 263-266

詳細
抄録
CS-600, sodium 2- (4- (2-oxocyclopentan-l-yl methyl) phenyl) propionate, which has potent anti-inflammatory and analgesic activities, showed a weak inhibitory activity to thein vitroPG synthesis with bovine seminal vesicle microsomes (IC50: 760μM) . Its main metabolite, which was produced by stereospecific reduction of the cyclopentanone moiety to hydroxy cyclopentane, exhibited a potent inhibitory activity (IC50: 9 μM) to the enzyme. The stereospecific configuration (trans-OH, SRS) was essential for the inhibitory activity. Oral administration of CS-600 to rats markedly decreased the urinary PGE2and F2α levels, suggesting that the active metabolite was produced and inhibited PG synthesisin vivo. In a culture system of 3T6 fibroblasts, CS-600 was effectively converted to the active metabolite and inhibited the PGE2production of the fibroblasts.
著者関連情報
© 日本炎症・再生医学会
前の記事 次の記事
feedback
Top